Pages that link to "Q48224915"

The following pages link to Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma. (Q48224915):

Displaying 36 items.

• Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo (Q26798185) (← links)
• The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases (Q26851670) (← links)
• Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum (Q28566901) (← links)
• Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens. (Q33652057) (← links)
• Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention (Q33663970) (← links)
• Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes (Q33911558) (← links)
• Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation (Q33936122) (← links)
• Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases (Q34179881) (← links)
• Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions (Q34238010) (← links)
• Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. (Q34259060) (← links)
• Microglia regulate the number of neural precursor cells in the developing cerebral cortex (Q34649089) (← links)
• Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis (Q35295564) (← links)
• Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain (Q36067379) (← links)
• Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. (Q36464494) (← links)
• Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury (Q36662869) (← links)
• Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders (Q36830470) (← links)
• Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention (Q36919403) (← links)
• Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage (Q36983964) (← links)
• A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells. (Q37015446) (← links)
• Astrocyte-derived proinflammatory cytokines induce hypomyelination in the periventricular white matter in the hypoxic neonatal brain (Q37538722) (← links)
• Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease. (Q37552024) (← links)
• Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease (Q37765220) (← links)
• Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases (Q39116758) (← links)
• Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. (Q42505593) (← links)
• Diabetic neuropathy: an evaluation of the use of quercetin in the cecum of rats (Q42696055) (← links)
• Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease. (Q45969431) (← links)
• Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy (Q47175712) (← links)
• Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats. (Q48793040) (← links)
• Brain injury-dependent expression of activity-dependent neuroprotective protein. (Q54699363) (← links)
• Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses (Q79913088) (← links)
• [Auricular chondritis. Experimental model in rats] (Q80196993) (← links)
• Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels (Q81167475) (← links)
• Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway (Q87499023) (← links)
• Microglia Receptors in Animal Models of Traumatic Brain Injury (Q90564251) (← links)
• Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens (Q92723094) (← links)
• Wikidata:WikiProject Chronic Pain/Microglias (← links | edit)